BioLineRx Ltd. Quarterly Entity Common Stock, Shares Outstanding from Q4 2017 to Q4 2023

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
BioLineRx Ltd. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q4 2017 to Q4 2023.
  • BioLineRx Ltd. Entity Common Stock, Shares Outstanding for the quarter ending December 31, 2023 was 1.09B shares, a 17.7% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 1.09B +164M +17.7% Dec 31, 2023 20-F/A 2024-03-26
Q4 2022 923M +208M +29.1% Dec 31, 2022 20-F 2023-03-22
Q4 2021 715M +366M +105% Dec 31, 2021 20-F 2022-03-16
Q4 2020 349M +178M +104% Dec 31, 2020 20-F 2021-02-23
Q4 2019 171M +56.3M +49% Dec 31, 2019 20-F 2020-03-12
Q4 2018 115M +9.87M +9.39% Dec 31, 2018 20-F 2019-03-28
Q4 2017 105M Dec 31, 2017 20-F 2018-03-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.